--- title: "FENC.US (FENC.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/FENC.US/news.md" symbol: "FENC.US" name: "FENC.US" parent: "https://longbridge.com/en/quote/FENC.US.md" datetime: "2026-03-15T23:50:32.572Z" locales: - [en](https://longbridge.com/en/quote/FENC.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/FENC.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/FENC.US/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/FENC.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/FENC.US/news.md) # FENC.US (FENC.US) — Related News ### [Stocks in Play: Fennec Pharmaceuticals Inc.](https://longbridge.com/en/news/277805612.md) *2026-03-04T15:47:17.000Z* > 10:42 AM EST - Fennec Pharmaceuticals Inc. : Today announced that the Tampa General Hospital Cancer Institute is initiat ### [Fagron acquires Vepakum in deal, with key locations in Belgium and the Netherlands, effective March 3, 2026.](https://longbridge.com/en/news/277570121.md) *2026-03-03T06:02:20.000Z* > Important details have been disclosed in Nazareth, Belgium and Rotterdam, The Netherlands on March 3, 2026 at 7:00AM. ### [Wedbush "Encouraged" by Study on Fennec's Pedmark's Impact on Adults Treated With Cisplatin](https://longbridge.com/en/news/276474884.md) *2026-02-20T18:11:00.000Z* > Wedbush is optimistic about Fennec Pharmaceuticals' (FENC) recent study showing potential hearing preservation in adults ### [Fennec Pharmaceuticals shares data showing PEDMARK® safe for adult head & neck cancer treatment, integrating easily.](https://longbridge.com/en/news/276440820.md) *2026-02-20T12:04:43.000Z* > Fennec Pharmaceuticals has reported that PEDMARK, when administered about six hours after cisplatin, is safe and can be ### [Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers | FENC Stock News](https://longbridge.com/en/news/276439790.md) *2026-02-20T04:03:00.000Z* > Fennec Pharmaceuticals presented new real-world data at the 2026 Multidisciplinary Head and Neck Cancers Symposium, show ### [Fennec Pharmaceuticals (TSE:FRX) Upgraded to Strong-Buy at B.Riley Securit](https://longbridge.com/en/news/275977185.md) *2026-02-14T11:37:27.000Z* > B.Riley Securities has upgraded Fennec Pharmaceuticals (TSE:FRX) to a "strong-buy" rating. The stock opened at C$10.50, ### [Adherex Technologies (NASDAQ:FENC) Upgraded at B.Riley Securit](https://longbridge.com/en/news/275977188.md) *2026-02-14T11:37:26.000Z* > B.Riley Securities upgraded Adherex Technologies (NASDAQ:FENC) to a "strong-buy" rating in a recent research note. Other ### [3 'Strong Buy' Stocks to Buy Now, 2/12/2026, According to Top Analysts](https://longbridge.com/en/news/275777502.md) *2026-02-12T15:18:43.000Z* > Top Wall Street Analysts recommend three stocks as 'Strong Buys': Fennec Pharmaceuticals (FENC) with a price target of $